Genomic profiling of advanced-stage oral cancers reveals chromosome 11q alterations as markers of poor clinical outcome.
Identifying oral cancer lesions associated with high risk of relapse and predicting clinical outcome remain challenging questions in clinical practice. Genomic alterations may add prognostic information and indicate biological aggressiveness thereby emphasizing the need for genome-wide profiling of...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2011-02-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC3046132?pdf=render |
| _version_ | 1811269164754534400 |
|---|---|
| author | Srikant Ambatipudi Moritz Gerstung Ravindra Gowda Prathamesh Pai Anita M Borges Alejandro A Schäffer Niko Beerenwinkel Manoj B Mahimkar |
| author_facet | Srikant Ambatipudi Moritz Gerstung Ravindra Gowda Prathamesh Pai Anita M Borges Alejandro A Schäffer Niko Beerenwinkel Manoj B Mahimkar |
| author_sort | Srikant Ambatipudi |
| collection | DOAJ |
| description | Identifying oral cancer lesions associated with high risk of relapse and predicting clinical outcome remain challenging questions in clinical practice. Genomic alterations may add prognostic information and indicate biological aggressiveness thereby emphasizing the need for genome-wide profiling of oral cancers. High-resolution array comparative genomic hybridization was performed to delineate the genomic alterations in clinically annotated primary gingivo-buccal complex and tongue cancers (n = 60). The specific genomic alterations so identified were evaluated for their potential clinical relevance. Copy-number changes were observed on chromosomal arms with most frequent gains on 3q (60%), 5p (50%), 7p (50%), 8q (73%), 11q13 (47%), 14q11.2 (47%), and 19p13.3 (58%) and losses on 3p14.2 (55%) and 8p (83%). Univariate statistical analysis with correction for multiple testing revealed chromosomal gain of region 11q22.1-q22.2 and losses of 17p13.3 and 11q23-q25 to be associated with loco-regional recurrence (P = 0.004, P = 0.003, and P = 0.0003) and shorter survival (P = 0.009, P = 0.003, and P 0.0001) respectively. The gain of 11q22 and loss of 11q23-q25 were validated by interphase fluorescent in situ hybridization (I-FISH). This study identifies a tractable number of genomic alterations with few underlying genes that may potentially be utilized as biological markers for prognosis and treatment decisions in oral cancers. |
| first_indexed | 2024-04-12T21:37:13Z |
| format | Article |
| id | doaj.art-cfec6fb60de34a40a54444a8885678d5 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-04-12T21:37:13Z |
| publishDate | 2011-02-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-cfec6fb60de34a40a54444a8885678d52022-12-22T03:15:52ZengPublic Library of Science (PLoS)PLoS ONE1932-62032011-02-0162e1725010.1371/journal.pone.0017250Genomic profiling of advanced-stage oral cancers reveals chromosome 11q alterations as markers of poor clinical outcome.Srikant AmbatipudiMoritz GerstungRavindra GowdaPrathamesh PaiAnita M BorgesAlejandro A SchäfferNiko BeerenwinkelManoj B MahimkarIdentifying oral cancer lesions associated with high risk of relapse and predicting clinical outcome remain challenging questions in clinical practice. Genomic alterations may add prognostic information and indicate biological aggressiveness thereby emphasizing the need for genome-wide profiling of oral cancers. High-resolution array comparative genomic hybridization was performed to delineate the genomic alterations in clinically annotated primary gingivo-buccal complex and tongue cancers (n = 60). The specific genomic alterations so identified were evaluated for their potential clinical relevance. Copy-number changes were observed on chromosomal arms with most frequent gains on 3q (60%), 5p (50%), 7p (50%), 8q (73%), 11q13 (47%), 14q11.2 (47%), and 19p13.3 (58%) and losses on 3p14.2 (55%) and 8p (83%). Univariate statistical analysis with correction for multiple testing revealed chromosomal gain of region 11q22.1-q22.2 and losses of 17p13.3 and 11q23-q25 to be associated with loco-regional recurrence (P = 0.004, P = 0.003, and P = 0.0003) and shorter survival (P = 0.009, P = 0.003, and P 0.0001) respectively. The gain of 11q22 and loss of 11q23-q25 were validated by interphase fluorescent in situ hybridization (I-FISH). This study identifies a tractable number of genomic alterations with few underlying genes that may potentially be utilized as biological markers for prognosis and treatment decisions in oral cancers.http://europepmc.org/articles/PMC3046132?pdf=render |
| spellingShingle | Srikant Ambatipudi Moritz Gerstung Ravindra Gowda Prathamesh Pai Anita M Borges Alejandro A Schäffer Niko Beerenwinkel Manoj B Mahimkar Genomic profiling of advanced-stage oral cancers reveals chromosome 11q alterations as markers of poor clinical outcome. PLoS ONE |
| title | Genomic profiling of advanced-stage oral cancers reveals chromosome 11q alterations as markers of poor clinical outcome. |
| title_full | Genomic profiling of advanced-stage oral cancers reveals chromosome 11q alterations as markers of poor clinical outcome. |
| title_fullStr | Genomic profiling of advanced-stage oral cancers reveals chromosome 11q alterations as markers of poor clinical outcome. |
| title_full_unstemmed | Genomic profiling of advanced-stage oral cancers reveals chromosome 11q alterations as markers of poor clinical outcome. |
| title_short | Genomic profiling of advanced-stage oral cancers reveals chromosome 11q alterations as markers of poor clinical outcome. |
| title_sort | genomic profiling of advanced stage oral cancers reveals chromosome 11q alterations as markers of poor clinical outcome |
| url | http://europepmc.org/articles/PMC3046132?pdf=render |
| work_keys_str_mv | AT srikantambatipudi genomicprofilingofadvancedstageoralcancersrevealschromosome11qalterationsasmarkersofpoorclinicaloutcome AT moritzgerstung genomicprofilingofadvancedstageoralcancersrevealschromosome11qalterationsasmarkersofpoorclinicaloutcome AT ravindragowda genomicprofilingofadvancedstageoralcancersrevealschromosome11qalterationsasmarkersofpoorclinicaloutcome AT prathameshpai genomicprofilingofadvancedstageoralcancersrevealschromosome11qalterationsasmarkersofpoorclinicaloutcome AT anitamborges genomicprofilingofadvancedstageoralcancersrevealschromosome11qalterationsasmarkersofpoorclinicaloutcome AT alejandroaschaffer genomicprofilingofadvancedstageoralcancersrevealschromosome11qalterationsasmarkersofpoorclinicaloutcome AT nikobeerenwinkel genomicprofilingofadvancedstageoralcancersrevealschromosome11qalterationsasmarkersofpoorclinicaloutcome AT manojbmahimkar genomicprofilingofadvancedstageoralcancersrevealschromosome11qalterationsasmarkersofpoorclinicaloutcome |